461 related articles for article (PubMed ID: 8923464)
1. An amino-terminal truncated progesterone receptor isoform, PRc, enhances progestin-induced transcriptional activity.
Wei LL; Hawkins P; Baker C; Norris B; Sheridan PL; Quinn PG
Mol Endocrinol; 1996 Nov; 10(11):1379-87. PubMed ID: 8923464
[TBL] [Abstract][Full Text] [Related]
2. Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
Leonhardt SA; Altmann M; Edwards DP
Mol Endocrinol; 1998 Dec; 12(12):1914-30. PubMed ID: 9849965
[TBL] [Abstract][Full Text] [Related]
3. Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo.
Tetel MJ; Giangrande PH; Leonhardt SA; McDonnell DP; Edwards DP
Mol Endocrinol; 1999 Jun; 13(6):910-24. PubMed ID: 10379890
[TBL] [Abstract][Full Text] [Related]
4. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
[TBL] [Abstract][Full Text] [Related]
5. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
[TBL] [Abstract][Full Text] [Related]
6. The constitution of a progesterone response element.
Lieberman BA; Bona BJ; Edwards DP; Nordeen SK
Mol Endocrinol; 1993 Apr; 7(4):515-27. PubMed ID: 8388996
[TBL] [Abstract][Full Text] [Related]
7. An N-terminally truncated third progesterone receptor protein, PR(C), forms heterodimers with PR(B) but interferes in PR(B)-DNA binding.
Wei LL; Norris BM; Baker CJ
J Steroid Biochem Mol Biol; 1997 Jul; 62(4):287-97. PubMed ID: 9408082
[TBL] [Abstract][Full Text] [Related]
8. 5'-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages.
Wei LL; Gonzalez-Aller C; Wood WM; Miller LA; Horwitz KB
Mol Endocrinol; 1990 Dec; 4(12):1833-40. PubMed ID: 2082185
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a truncated progesterone receptor protein in breast tumors.
Yeates C; Hunt SM; Balleine RL; Clarke CL
J Clin Endocrinol Metab; 1998 Feb; 83(2):460-7. PubMed ID: 9467558
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the existence of a third progesterone receptor protein in human breast cancer cell line T47D.
Wei LL; Miner R
Cancer Res; 1994 Jan; 54(2):340-3. PubMed ID: 8275464
[TBL] [Abstract][Full Text] [Related]
11. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
Horwitz KB
Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor (PR) inhibits expression of insulin-like growth factor-binding protein-1 (IGFBP-1) in human endometrial cell line HEC-1B: characterization of the inhibitory effect of PR on the distal promoter region of the IGFBP-1 gene.
Gao J; Tseng L
Mol Endocrinol; 1997 Jun; 11(7):973-9. PubMed ID: 9178756
[TBL] [Abstract][Full Text] [Related]
13. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
14. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
McGowan EM; Clarke CL
Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
[TBL] [Abstract][Full Text] [Related]
15. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.
Tung L; Mohamed MK; Hoeffler JP; Takimoto GS; Horwitz KB
Mol Endocrinol; 1993 Oct; 7(10):1256-65. PubMed ID: 8123133
[TBL] [Abstract][Full Text] [Related]
16. Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
Hurd C; Underwood B; Herman M; Iwasaki K; Kloosterboer HJ; Dinda S; Moudgil VK
Mol Cell Biochem; 1997 Oct; 175(1-2):205-12. PubMed ID: 9350053
[TBL] [Abstract][Full Text] [Related]
17. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor and the mechanism of action of progesterone antagonists.
Edwards DP; Altmann M; DeMarzo A; Zhang Y; Weigel NL; Beck CA
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):449-58. PubMed ID: 7626494
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional activity of progestins used in contraception and menopausal hormone therapy via progesterone receptor A is dependent on the density of the receptor.
Cartwright M; Toit RL; Africander D
Biochem Biophys Res Commun; 2023 Jan; 639():70-76. PubMed ID: 36470074
[TBL] [Abstract][Full Text] [Related]
20. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor.
DeMarzo AM; Oñate SA; Nordeen SK; Edwards DP
Biochemistry; 1992 Nov; 31(43):10491-501. PubMed ID: 1420166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
